KALAMAZOO, Mich., March 13 /PRNewswire-FirstCall/ -- Stryker Corporation
(NYSE: SYK) announced that it will host a conference call on Monday, April 20,
2009 at 4:30 p.m., Eastern Time, to discuss the Company's operating results
for the quarter ended March 31, 2009, and provide an operational update.
Operating results for the quarter ended March 31, 2009 will be released at
4:00 p.m. that day.
To participate in the conference call dial 866-700-5192 (domestic) or
617-213-8833 (international) and enter the participant passcode 24899716. A
simultaneous webcast of the call will be accessible via the Company's website
at www.stryker.com. The call will be archived on this site for 90 days.
A recording of the call will also be available from 7:30 p.m., Eastern
Time, on Monday, April 20, 2009, until 7:30 p.m. on Monday, April 27, 2009. To
hear this recording, dial 888-286-8010 (domestic) or 617-801-6888
(international) and enter the passcode 86263096.
Certain statements made during the call may constitute forward-looking
statements. They will be based upon management's current expectations and will
be subject to various risks and uncertainties that could cause the Company's
actual results to differ materially from those expressed or implied in such
statements. Such factors include, but are not limited to: further weakening of
economic conditions that could adversely affect the level of demand for the
Company's products; pricing pressures generally, including cost-containment
measures that could adversely affect the price of or demand for the Company's
products; changes in foreign exchange markets; regulatory actions;
unanticipated issues arising in connection with clinical studies and otherwise
that affect U.S. Food and Drug Administration approval of new products;
changes in reimbursement levels from third-party payors; a significant
increase in product liability claims; changes in financial markets; and
changes in the competitive environment. Additional information concerning
these and other factors is contained in the Company's filings with the U.S.
Securities and Exchange Commission, including the Company's Annual Report on
Form 10-K and Quarterly Reports on Form 10-Q.
Stryker Corporation is one of the world's leading medical technology
companies with the most broadly based range of products in orthopaedics and a
significant presence in other medical specialties. Stryker works with
respected medical professionals to help people lead more active and more
satisfying lives. The Company's products include implants used in joint
replacement, trauma, craniomaxillofacial and spinal surgeries; biologics;
surgical, neurologic, ear, nose & throat and interventional pain equipment;
endoscopic, surgical navigation, communications and digital imaging systems;
as well as patient handling and emergency medical equipment. For more
information about Stryker, please visit www.stryker.com.
SOURCE Stryker Corporation
CONTACT: Katherine A. Owen, Vice President, Strategy and Investor
Web Site: http://www.stryker.com